Therapeutics Discovery and DevelopmentTDD - Antibodies. A clinical stage biopharmaceutical company that is leveraging its proprietary research to treat significant unmet needs in cancer and infectious disease. In order to destroy such cancerous or infected cells, Scancell uses either vaccines to induce immune responses or monoclonal antibodies to redirect immune cells or drugs.